Our company’s co-founder Dr. Hatim Hemeda is author of a number of publications related to human Platelet Lysate:
Publications
HUMAN PLATELET LYSATE-RELATED PAPERS
- Lenz M., Goetzke R., Schenk A., Schubert C., Veeck J., Hemeda H., Koschmieder S., Zenke M., Schuppert A. & Wagner W. Epigenetic Biomarker to Support Classification into Pluripotent and Non-Pluripotent Cells. Scientific Reports. 2015; 5:8973. doi:10.1038/srep089731.
- Hemeda H., Wagner W. & Giebel B. Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy. 2014; 16(2):170-180.
- Frobel F., Hemeda H., Lenz M., Abagnale G., Joussen S., Denecke B., Šarić T., Zenke M. & Wagner W. Epigenetic Rejuvenation of Mesenchymal Stromal Cells Derived from Induced Pluripotent Stem Cells. Stem Cell Reports. 2014; Vol. 3; 414–422.
- Schellenberg A., Joussen S., Moser K., Hampe N., Hersche N., Hemeda H., Schnitker J., Denecke B., Qiong L., Pallua N., Zenke M., Merkel R., Hoffmann B. & Wagner W. Matrix elasticity, replicative senescenece and DNA methylation patterns of mesenchymal stem cells. Biomaterials. 2014; 35(24):6351-6358.
- Hemeda H., Kalz J., Walenda G., Lohmann M. & Wagner W. Heparin concentration is critical for cell culture with human platelet lysate. Cytotherapy. 2013; 15(9):1174-1181.
- Lohmann M., Walenda G., Hemeda H., Joussen S., Drescher W., Jockenhoevel S., Hutschenreuter G., Zenke M. & Wagner W. Donor age of human platelet lysate affects proliferation and differentation of mesenchymal stem cells. PLoS ONE . 2012; 7(5): e37839. doi:10.1371/journal.pone.0037839.
- Walenda G., Hemeda H., Schneider R. K., Merkel R., Hoffmann B. & Wagner W. Human platelet lysate gel provides a novel three dimensional-matrix for enhanced culture expansion of mesenchymal stromal cells. Tissue Eng Part C Methods. 2012; 18(12):924-934.